- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02505958
How Quickly Can the Effects of Excessive Caloric Intake on Insulin Resistance be Reversed?
July 25, 2022 updated by: Temple University
Objective: To show that a 1-2 day reduction of caloric intake can reduce the insulin resistance produced by several days of overnutrition.
Approach: Healthy volunteers will be admitted to the Clinical Research Center and undergo a baseline euglycemic-hyperinsulinemic clamp study to assess their insulin resistance.
Subjects will then start on an overnutrition program for 4 days consisting of 3 meals and 3 snacks containing ~6,000 Kcal/24hours.
A second clamp study will be performed on day 5 to demonstrate the overnutrition induced increase in insulin resistance.
Starting on day 5 the subject's caloric intake will be reduced to ~1,000 Kcal for 2 days (day 5 and 6).
After that on the morning of day 7, a third hyperinsulinemic-euglycemic clamp will be performed to determine whether the reduced caloric intake did reduce insulin resistance and the volunteer will be discharged from the Clinical Research Center.
Study Overview
Status
Active, not recruiting
Conditions
Intervention / Treatment
Detailed Description
Study volunteers will be admitted to the Clinical Research Center at Temple University Hospital.
After an overnight fast, body composition will be determined non-invasively by bioimpedance analysis (4) and a 4 h euglycemic-hyperinsulinemic clamp (using only FDA-approved regular insulin) as previously described (5) will be performed during which serum samples will be obtained for measurement of glucose, insulin, free fatty acids, ketone bodies and lipids.
Oxidative stress ( 6) will be measured by 24 hour urine collections (analyzed for isoprostane content via 8-isoprostaglandin-F2alpha throughout the study period.
Respiratory gas exchange rates (7) will be determined at hourly intervals (with a metabolic cart (True One, Parvo Utah) during the clamp studies and once a day on Days 2 through 6.
After that, (at about 1:00 in the afternoon on Day 1) the volunteers will be started on a diet program for 4 ½ days, consisting of 3 meals and 3 snacks over a 24 hour period and containing ~ 6000 Kcal/24 h.
The main meals (containing ~ 1500 Kcal/meal) will be served at ~ 8:00 in the morning (breakfast), 1:00 in the afternoon (lunch) and approximately 7:00 in the evening (dinner), the snacks (~ 500 Kcal/each) at approximately 11:00 in the morning, 4:00 in the afternoon and 11:00 in the night.
On days 5 and 6, volunteers will receive 3 meals, each will contain ~333 calories.
Each morning blood samples will be obtained to measure glucose insulin, free fatty acids and ketone bodies.
Daily 24 h urine collections will be obtained each day.
In the morning of Days 5 and 7, all procedures described for Day 1 will be repeated.
In the afternoon of Day 7, the volunteers will be discharged from the hospital.
Study Type
Interventional
Enrollment (Actual)
1
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Pennsylvania
-
Philadelphia, Pennsylvania, United States, 19140
- Temple University Hospital
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years to 70 years (Adult, Older Adult)
Accepts Healthy Volunteers
Yes
Genders Eligible for Study
All
Description
Inclusion Criteria: Healthy non-obese men and women -
Exclusion Criteria: Subjects with diabetes or a history of obesity surgery or with more than modest health problems
-
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Other
- Allocation: Non-Randomized
- Interventional Model: Crossover Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Other: high caloric intake
Volunteers will receive 3 meals and 3 snacks over a 24 hour period which will contain ~ 6,000 calories.
Main meals will consist of ~ 1,500 calories and snacks will contain ~ 500 calories.
|
Volunteers will be started on a diet program for 4 ½ days, consisting of 3 meals and 3 snacks over a 24 hour period and containing ~ 6000 Kcal/24 h.
|
|
Other: reduced caloric intake
On days 5 and 6 subjects will receive 3 meals only and each meal will contain ~ 333 calories for a total of 1,000/ 24 hours.
|
On days 5 and 6, volunteers will received 3 meals (~333 calories each) totaling ~ 1,000 calories/24 hours.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Changes in insulin resistance
Time Frame: baseline, day 4 and day 7
|
Insulin resistance will be determined by measuring changes in insulin-stimulated total body glucose uptake during euglycemic hyperinsulinemic clamping
|
baseline, day 4 and day 7
|
|
Changes in oxidative stress
Time Frame: baseline, day1, day 2, day 3, day 4, day 5, day 6, day 7
|
24 hour urine collections analyzed for isoprostane content
|
baseline, day1, day 2, day 3, day 4, day 5, day 6, day 7
|
|
Changes in energy expenditure
Time Frame: baseline, day 1, day 2, day 3, day 4, day 5, day 6, day 7
|
Changes in energy expenditure will be assessed with a metabolic cart (indirect calorimetry)
|
baseline, day 1, day 2, day 3, day 4, day 5, day 6, day 7
|
|
Changes in weight
Time Frame: baseline, day 1, day 2, day 3, day 4, day 5, day 6, day 7
|
Subjects will be weighed daily
|
baseline, day 1, day 2, day 3, day 4, day 5, day 6, day 7
|
|
Changes in body composition
Time Frame: baseline, day 1, day 2, day 3, day 4, day 5, day 6, day 7
|
Body composition will be determined by bioelectric impedance analysis
|
baseline, day 1, day 2, day 3, day 4, day 5, day 6, day 7
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Changes in blood glucose levels
Time Frame: baseline, day 1, day 2, day 3, day 4, day 5, day 6, day 7
|
Daily blood samples will be analyzed to determine glucose levels of glucose.
|
baseline, day 1, day 2, day 3, day 4, day 5, day 6, day 7
|
|
Changes in blood levels of insulin
Time Frame: Baseline, day1 day2, day 3, day 4, day 5, day 6, day 7
|
Daily blood samples will be analyzed to determine insulin levels
|
Baseline, day1 day2, day 3, day 4, day 5, day 6, day 7
|
|
Changes in blood levels of free fatty acids
Time Frame: Baseline, day1 , day 2, day 3, day 4, day 5, day 6, day 7
|
Daily blood samples will be analyzed to determine free fatty acid levels
|
Baseline, day1 , day 2, day 3, day 4, day 5, day 6, day 7
|
|
Changes in blood ketone levels
Time Frame: baseline, day 1, day 2, day 3, day 4, day 5, day 6, day 7
|
Daily blood samples will be analyzed to determine ketone levels
|
baseline, day 1, day 2, day 3, day 4, day 5, day 6, day 7
|
|
Changes in glucagon levels
Time Frame: baseline, day 1, day 2, day 3, day 4, day 5, day 6, day 7
|
Daily blood samples will be analyzed to determine glucagon levels
|
baseline, day 1, day 2, day 3, day 4, day 5, day 6, day 7
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Ajaykumar Rao, MD, Temple University
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
August 1, 2014
Primary Completion (Anticipated)
December 31, 2022
Study Completion (Anticipated)
December 31, 2023
Study Registration Dates
First Submitted
July 21, 2015
First Submitted That Met QC Criteria
July 21, 2015
First Posted (Estimate)
July 22, 2015
Study Record Updates
Last Update Posted (Actual)
July 28, 2022
Last Update Submitted That Met QC Criteria
July 25, 2022
Last Verified
July 1, 2022
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 22331
- R01DK090588 (U.S. NIH Grant/Contract)
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Obesity
-
Dr. Christopher McGowanRecruitingObesity Prevention | Obesity Recidivism | Obesity and Overweight | Obesity and Obesity-related Medical ConditionsUnited States
-
Central Hospital, Nancy, FranceNot yet recruiting
-
Helsinki University Central HospitalKarolinska Institutet; Folkhälsan Researech CenterEnrolling by invitation
-
Washington University School of MedicinePatient-Centered Outcomes Research Institute; Pennington Biomedical Research... and other collaboratorsCompletedOvernutrition | Nutrition Disorders | Overweight | Body Weight | Pediatric Obesity | Body Weight Changes | Childhood Obesity | Weight Gain | Adolescent Obesity | Obesity, Childhood | Overweight and Obesity | Overweight or Obesity | Overweight AdolescentsUnited States
-
Istanbul Medipol University HospitalMedipol UniversityCompletedObesity, Morbid | Obesity, Adolescent | Obesity, Abdominal | Weight, Body | Obesity, VisceralTurkey
-
Dr. Christopher McGowanRecruitingObesity Prevention | Obesity Recidivism | Obesity and Overweight | GLP-1 | Obesity and Obesity-related Medical Conditions | Ablation TechniquesUnited States
-
The Hospital for Sick ChildrenCompleted
-
Ihuoma EneliCompletedObesity, ChildhoodUnited States
-
Azienda Ospedaliero-Universitaria Consorziale Policlinico...Institute of Biomembranes, Bioenergetics and Molecular Biotechnologies; Istituti... and other collaboratorsCompletedMorbid Obesity | Metabolically Healthy ObesityItaly
-
Queen Fabiola Children's University HospitalNot yet recruitingMorbid Obesity | Adolescent Obesity | Bariatric SurgeryBelgium
Clinical Trials on high caloric intake
-
University of ChicagoWithdrawn
-
University of ChicagoNorthwestern University; National Institute on Aging (NIA)Active, not recruitingCardiovascular Diseases | Type2 Diabetes MellitusUnited States
-
University of MichiganNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)TerminatedWeight Gain | Glomerular Disease | Kidney Transplant; Complications | Kidney TransplantUnited States
-
Albert Christian Ludolph, Prof.Nutritia GmbH, 91052 Erlangen, GermanyCompletedAmyotrophic Lateral SclerosisGermany
-
Arizona State UniversityRecruitingDehydration | Dehydration (Physiology) | Cardiovascular | Glucose AbnormalitiesUnited States
-
University Hospital TuebingenCompletedType 2 Diabetes Mellitus | Liver Fat | Insulin Sensitivity | Nutritional and Metabolic DiseasesGermany
-
Medical University of BialystokMinistry of Science and Higher Education, PolandCompletedDiabetes Mellitus, Type 2 | Metabolic Syndrome | Diet Modification | Overweight and Obesity | Genetic PredispositionPoland
-
Fresenius KabiCompleted
-
Fresenius KabiCompleted
-
Asan Medical CenterUnknown